CONTENTS:
- New data confirm lack of progress in harm reduction after three decades of proven evidence of effectiveness [Editorial]. Macdonald V., Mathers B., Sabin K., Me A., Carpentier C., Niaz K., et al., p. 1411-1413.
- Comparative effectiveness of psychosocial interventions in adults with harmful use of alcohol: a systematic review and network meta-analysis. Tan C.J., Shufelt T., Behan E., Chantara J., Koomsri C., Gordon A.J., et al., p. 1414-1429.
- Global prevalence of heated tobacco product use, 2015-22: A systematic review and meta-analysis. Sun T., Anandan A., Lim C.C.W., East K., Xu S.S., Quah A.C.K., et al., p. 1430-1444.
- Financial incentives for quitting smoking in pregnancy: Are they cost-effective? McMeekin N., Sinclair L., Robinson-Smith L., Mitchell A., Bauld L., Tappin D.M., et al., p. 1445-1456.
- Alcohol use disorder criteria exhibit different comorbidity patterns. Watts A.L., Watson D., Heath A.C., Sher K.J., p. 1457-1468.
- Commentary on Watts et al.: What can comorbidity teach us about the nature of alcohol problems? Baillie A.J., p. 1469-1470.
- An overlooked effect: domestic violence and alcohol policies in the night-time economy. Kowalski M., Livingston M., Wilkinson C., Ritter A., p. 1471-1481.
- Influence of vaccination on adverse health outcomes after SARS-CoV-2 infection among individuals with alcohol use disorder: a population-based study. Askgaard G., Osler M., Laursen T.M., Hjorthoj C., Benros M.E., Ethelberg S., et al., p. 1482-1492.
- Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross-sectional study. Grigg J., Manning V., Cheetham A., Greenwood C.J., Youssef G., Lockie D., et al., p. 1493-1506.
- High-'n'-dry? A comparison of cannabis and alcohol use in drivers presenting to hospital after a vehicular collision. Brubacher J.R., Chan H., Erdelyi S., Yuan Y., Daoust R., Vaillancourt C., et al., p. 1507-1516.
- The effect of recreational cannabis legalization on rates of traffic injury in Canada. Walker M., Saarela O., Mann R., Carpino M., Cusimano M.D., p. 1517-1526.
- Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17. Larney S., Jones N.R., Hickman M., Nielsen S., Ali R., Degenhardt L., p. 1527-1539.
- Community member perspectives on adapting the cascade of care for opioid use disorder for a tribal nation in the United States. Johnson F., Jr., RedCloud A., Mootz J., Hallgren K.A., Elliott K., Alexander C., et al., p. 1540-1548.
- Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety. Saloner B., Whitley P., Dawson E., Passik S., Gordon A.J., Stein B.D., p. 1549-1556.
- The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia. Rathnayake K., Agius P.A., Ward B., Hickman M., Maher L., Stoové M., et al., p. 1557-1568.
- Using machine learning to retrospectively predict self-reported gambling problems in Quebec. Murch W.S., Kairouz S., Dauphinais S., Picard E., Costes J.M., French M., p. 1569-1578.
- Effect of perioperative high-dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study. Zhu C., Bi Y., Wei K., Tao K., Hu L., Lu Z., p. 1579-1585.
- Use of the BACtrack Skyn alcohol biosensor: Practical applications for data collection and analysis. Gunn R.L., Merrill J.E., Haines A.M., Fernandez M.E., Souza T., Berey B.L., et al., p. 1586-1595.
- Seasonal, weekly and other cyclical patterns in deaths due to drug poisoning in England and Wales. Lewer D., Brothers T.D., Gasparrini A., Strang J., p. 1596-1601.